🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (taza...
Status
Completed
Location
Valeant Site 03
Start Date
2015-11
Trial ID
NCT02938494
Treatments Being Tested
The primary objective of this study is to compare the safety and efficacy o...
Status
Unknown
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02525822
Treatments Being Tested
To determine the efficacy and safety of 12 weeks of treatment with Differin...
Status
Completed
Location
Therapeutics Clinical Research
Start Date
2006-02
Trial ID
NCT00469755
Treatments Being Tested
To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to t...
Status
Completed
Location
Altman Dermatology Associates
Start Date
2014-05
Trial ID
NCT02160678
Treatments Being Tested
Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared wit...
Status
Terminated
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00829049
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy profiles of...
Status
Completed
Location
Altman Dermatology Associates
Start Date
2014-05
Trial ID
NCT02160665
Treatments Being Tested
To determine and compare the safety and efficacy of broad area photodynamic...
Status
Completed
Location
Roger Stewart MD PA
Start Date
2010-01
Trial ID
NCT01053000
Treatments Being Tested
The purpose of this study is to evaluate the therapeutic equivalence and sa...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02411955
Treatments Being Tested
A study for Subjects with mild to moderate facial acne vulgaris. During the...
Status
Completed
Location
International Dermatology Inc.
Start Date
2017-08-21
Trial ID
NCT03341910
Treatments Being Tested
This is a safety, tolerability and pharmacokinetics study of AGN-190168 in ...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02218034
Treatments Being Tested